Clinical significance of renal biopsy in diabetic patients with kidney injury

doi:10.3877/cma.j.issn.2095-3216.2015.02.008

Abstract

Abstract:

Diabetic kidney disease (DKD) is a main cause of chronic renal failure, among which type 2 diabetes-induced kidney disease accounts for the majority. Renal biopsy pathology examination is a "golden standard" for diagnosis, of important value for choice of treatment regimen and prognosis judgement, of important significance for new drug development, and also important basis for epidemiological investigation, determining clinical-pathological relation, and developing noninvasive diagnostic methods for DKD. Therefore, it is of important significance to positively perform renal biopsy examination in diabetic, particularly type 2 diabetic patients with kidney injury.

Key words: Diabetes mellitus, Diabetic kidney disease, Non-diabetic renal disease, Renal biopsy, Renal pathology

Zheyi Dong, Qiang Qiu, Xiangmei Chen. Clinical significance of renal biopsy in diabetic patients with kidney injury[J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2015, 04(02): 92-96.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhsbyjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3216.2015.02.008

https://zhsbyjdzzz.cma-cmc.com.cn/EN/Y2015/V04/I02/92

References 46

[1]	Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China [J]. N Engl J Med, 2010, 362(12): 1090-1101.
[2]	Xu Y, Wang L, He J, et al. Prevalence and control of diabetes in Chinese adults [J]. JAMA, 2013, 310(9): 948-959.
[3]	de Boer IH, Rue TC, Hall YN, et al. Temporal trends in the prevalence of diabetic kidney disease in the United States [J]. JAMA, 2011, 305(24): 2532-2539.
[4]	Gregg EW, Li Y, Wang J, et al. Changes in diabetes-related complications in the United States, 1990-2010 [J]. N Engl J Med, 2014, 370(16): 1514-1523.
[5]	卫生计生委医政医管局、国家肾病学专业医疗质量管理与控制中心. 全国血液透析患者病例信息登记系统[DB/OL]. 2012，2013, [2014-10-20]. URL
[6]	KDOQI. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease [J]. Am J Kidney Dis, 2007, 49(2 Suppl 2): S12-S154.
[7]	Gosmanov AR, Wall BM, Gosmanova EO. Diagnosis and treatment of diabetic kidney disease [J]. Am J Med Sci, 2014, 347(5): 406-413.
[8]	Soni SS, Gowrishankar S, Kishan AG, et al. Non diabetic renal disease in type 2 diabetes mellitus [J]. Nephrology (Carlton), 2006, 11(6): 533-537.
[9]	Shimizu M, Furuichi K, Toyama T, et al. Long-term outcomes of Japanese type 2 diabetic patients with biopsy-proven diabetic nephropathy [J]. Diabetes Care, 2013, 36(11): 3655-3662.
[10]	Pergola PE, Raskin P, Toto RD, et al. Bardoxolone methyl and kidney function in CKD with type 2 diabetes [J]. N Engl J Med, 2011, 365(4): 327-336.
[11]	de Zeeuw D, Akizawa T, Audhya P, et al. Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease [J]. N Engl J Med, 2013, 369(26): 2492-2503.
[12]	Lewis EJ, Lewis JB, Greene T, et al. Sulodexide for kidney protection in type 2 diabetes patients with microalbuminuria: a randomized controlled trial [J]. Am J Kidney Dis, 2011, 58(5): 729-736.
[13]	Packham DK, Wolfe R, Reutens AT, et al. Sulodexide fails to demonstrate renoprotection in overt type 2 diabetic nephropathy [J]. J Am Soc Nephrol, 2012, 23(1): 123-130.
[14]	Huang F, Yang Q, Chen L, et al. Renal pathological change in patients with type 2 diabetes is not always diabetic nephropathy: a report of 52 cases [J]. Clin Nephrol, 2007, 67(5): 293-297.
[15]	Parving HH, Hommel E, Mathiesen E, et al. Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes [J]. Br Med J (Clin Res Ed), 1988, 296(6616): 156-160.
[16]	Parving HH, Gall MA, Skott P, et al. Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients[J]. Kidney Int, 1992, 41(4): 758-762.
[17]	Bakris GL, Molitch M. Microalbuminuria as a risk predictor in diabetes: the continuing saga[J]. Diabetes Care, 2014, 37(3): 867-875.
[18]	American Diabetes Association. Standards of medical care in diabetes-2013 [J]. Diabetes Care, 2013, 36(Suppl 1): S11-S66.
[19]	de Boer IH, Rue TC, Cleary PA, et al. Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort [J]. Arch Intern Med, 2011, 171(5): 412-420.
[20]	Krolewski AS, Niewczas MA, Skupien J, et al. Early progressive renal decline precedes the onset of microalbuminuria and its progression to macroalbuminuria [J]. Diabetes Care, 2014, 37(1): 226-234.
[21]	Pavkov ME, Knowler WC, Lemley KV, et al. Early renal function decline in type 2 diabetes [J]. Clin J Am Soc Nephrol, 2012, 7(1): 78-84.
[22]	Christensen PK, Larsen S, Horn T, et al. Causes of albuminuria in patients with type 2 diabetes without diabetic retinopathy [J]. Kidney Int, 2000, 58(4): 1719-1731.
[23]	Prakash J, Lodha M, Singh SK, et al. Diabetic retinopathy is a poor predictor of type of nephropathy in proteinuric type 2 diabetic patients [J]. J Assoc Physicians India, 2007, 55: 412-416.
[24]	He F, Xia X, Wu XF, et al. Diabetic retinopathy in predicting diabetic nephropathy in patients with type 2 diabetes and renal disease: a meta-analysis [J]. Diabetologia, 2013, 56(3): 457-466.
[25]	Liu MY, Chen XM, Sun XF, et al. Validation of a differential diagnostic model of diabetic nephropathy and non-diabetic renal diseases and the establishment of a new diagnostic model [J]. J Diabetes, 2014, 6(6): 519-526.
[26]	Oh SW, Kim S, Na KY, et al. Clinical implications of pathologic diagnosis and classification for diabetic nephropathy [J]. Diabetes Res Clin Pract, 2012, 97(3): 418-424.
[27]	Akimoto T, Ito C, Saito O, et al. Microscopic hematuria and diabetic glomerulosclerosis--clinicopathological analysis of type 2 diabetic patients associated with overt proteinuria [J]. Nephron Clin Pract, 2008, 109(3): c119-c126.
[28]	Kleinknecht D, Bennis D, Altman JJ. Increased prevalence of non-diabetic renal pathology in type II diabetes mellitus [J]. Nephrol Dial Transplant, 1992, 7(12): 1258-1259.
[29]	Mazzucco G, Bertani T, Fortunato M, et al. Different patterns of renal damage in type 2 diabetes mellitus: a multicentric study on 393 biopsies [J]. Am J Kidney Dis, 2002, 39(4): 713-720.
[30]	Prakash J, Sen D, Usha, et al. Non-diabetic renal disease in patients with type 2 diabetes mellitus [J]. J Assoc Physicians India, 2001, 49: 415-420.
[31]	Wilfred DC, Mysorekar VV, Venkataramana RS, et al. Nondiabetic renal disease in type 2 diabetes mellitus patients: a clinicopathological study [J]. J Lab Physicians, 2013, 5(2): 94-99.
[32]	Pham TT, Sim JJ, Kujubu DA, et al. Prevalence of nondiabetic renal disease in diabetic patients [J]. Am J Nephrol, 2007, 27(3): 322-328.
[33]	Lin YL, Peng SJ, Ferng SH, et al. Clinical indicators which necessitate renal biopsy in type 2 diabetes mellitus patients with renal disease [J]. Int J Clin Pract, 2009, 63(8): 1167-1176.
[34]	Das U, Dakshinamurty KV, Prayaga A, et al. Nondiabetic kidney disease in type 2 diabetic patients: a single center experience [J]. Indian J Nephrol, 2012, 22(5): 358-362.
[35]	Chang TI, Park JT, Kim JK, et al. Renal outcomes in patients with type 2 diabetes with or without coexisting non-diabetic renal disease [J]. Diabetes Res Clin Pract, 2011, 92(2): 198-204.
[36]	Tervaert TW, Mooyaart AL, Amann K, et al. Pathologic classification of diabetic nephropathy [J]. J Am Soc Nephrol, 2010, 21(4): 556-563.
[37]	Zhuo L, Ren W, Li W, et al. Evaluation of renal biopsies in type 2 diabetic patients with kidney disease: a clinicopathological study of 216 cases [J]. Int Urol Nephrol, 2013, 45(1): 173-179.
[38]	Sharma SG, Bomback AS, Radhakrishnan J, et al. The modern spectrum of renal biopsy findings in patients with diabetes [J]. Clin J Am Soc Nephrol, 2013, 8(10): 1718-1724.
[39]	Stanton RC. Clinical challenges in diagnosis and management of diabetic kidney disease [J]. Am J Kidney Dis, 2014, 63(2 Suppl 2): S3-S21.
[40]	Caramori ML, Parks A, Mauer M. Renal lesions predict progression of diabetic nephropathy in type 1 diabetes [J]. J Am Soc Nephrol, 2013, 24(7): 1175-1181.
[41]	Haas M, Spargo BH, Wit EJ, et al. Etiologies and outcome of acute renal insufficiency in older adults: a renal biopsy study of 259 cases [J]. Am J Kidney Dis, 2000, 35(3): 433-447.
[42]	Corapi KM, Chen JL, Balk EM, et al. Bleeding complications of native kidney biopsy: a systematic review and meta-analysis [J]. Am J Kidney Dis, 2012, 60(1): 62-73.
[43]	American Diabetes Association. Clinical Practice Recommendations 2005 [J]. Diabetes Care, 2005, 28(Suppl 1): S1-S79.
[44]	Kumar J, Sahai G. Non-diabetic renal diseases in diabetics [J]. Clin Quer: Nephrol, 2012, 1(2): 172-177.
[45]	Hovind P, Rossing P, Tarnow L, et al. Progression of diabetic nephropathy [J]. Kidney Int, 2001, 59(2): 702-709.
[46]	Zhang PP, Ge YC, Li SJ, et al. Renal biopsy in type 2 diabetes: timing of complications and evaluating of safety in Chinese patients [J]. Nephrology (Carlton), 2011, 16(1): 100-105.

Please choose a citation manager

Content to export